期刊文献+

氨基酸末端脑钠素前体与心房颤动的相关性研究 被引量:2

Clinical study of relationship between NT-proBNP and atrial fibrillation
原文传递
导出
摘要 目的探讨血清中氨基酸末端脑钠素前体(NT-proBNP)水平与心房颤动(房颤)之间的关系。方法病例组心血管病患者136例,心功能Ⅰ-Ⅱ级(NYHA分级),其中房颤患者90例,窦性心律患者46例;健康对照组30例。应用竞争性酶联免疫分析(ELISA)定量测定血清中NT-proBNP水平,并进行统计学分析。结果房颤患者血清NT-proBNP水平显著高于窦性心律患者和对照组(P< 0.01),窦性心律患者与对照组之间血清NT-proBNP水平差异无统计学意义(P>0.05);房颤、年龄、右心房内径是血清NT-proBNP水平升高的独立预测因素。结论房颤患者血清NT-proBNP水平明显升高,监测血清NT-proBNP水平的变化有助于房颤患者心功能的评价。 Objective To investigate the relationship between serum N-terminal fragment pro-brain natriuretic peptide(NT-proBNP) levels and atrial fibrillation (AF). Methods Serum NT-proBNP levels were measured by ELISA in 136 subjects(90 with AF, 46 in sinus rhythm). Subjects were excluded if they had a history of myocardial infarction, cardiomyopathy, rheumatic heart disease, or hyperthyroidism that proceded the onset of AF. Control subjects(30) were obtained from a healthy outpatient primary care population. Potential determinants of serum NT-proBNP levels were identified by univariate and multivariate. Results Individuals with AF had higher serum NT-pro BNP levels than those with sinus rhythm and control subjects( P 〈 0. 01, respectively). In individuals with sinus rhythm and control subjects did not show difference at serum NT-proBNP levels ( P 〉 0. 05 ). The final regression model showed that presence of AF, older age and larger right atrial diameter were independent predictors of higher serum NT-proBNP values. Conclusions Presence of AF in patients is associated with elevated serum NT-proBNP levels. Examining the change of serum NT-proBNP levels has evaluation value in cardiac function of patients with AF.
出处 《中华心律失常学杂志》 2006年第5期375-378,共4页 Chinese Journal of Cardiac Arrhythmias
关键词 氨基酸末端脑钠素前体 心房颤动 窦性心律 N-terminal fragment pro-brain natriuretic peptide Atrial fibrillation Sinus rhythm
  • 相关文献

参考文献19

  • 1张国华,胡韵,史晓敏,徐国宾,夏铁安.B型钠尿肽的生物学特性及其在心脏病学中的临床应用进展[J].中华检验医学杂志,2004,27(4):262-265. 被引量:75
  • 2Ogawa Y,Itoh H,Nakao K.Molecular biology and biochemistry of natriuretic peptide family.Clin Exp Pharmacol Physiol,1995,22:49-53.
  • 3Tuinenburg AE,Brundel BJ,Van Gelder IC,et al.Gene expression of the natriuretic peptide system in atrial tissue of patients with paroxysmal and persistent atrial fibrillation.J Cardiovasc Electrophysiol,1999,10:827-835.
  • 4Inoue S,Murakami Y,Sano K,et al.Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation.J Card Fail,2000,6:92-96.
  • 5Benjamin EJ,Wolf PA,Agostino RB,et al.Impact of atrial fibrillation on the risk of death:the Framingham Heart Study.Circulation,1998,98,946-952.
  • 6Mabuchi N,Tsutamoto T,Maeda K,et al.Plasma cardiac natriuretic peptides as biochemical markers of recurrence of atrial fibrillation in patients with mild congestive heart failure.Jpn Circ J,2000,64:765-771.
  • 7Shimizu H,Murakami Y,Inoue S,et al.High plasma brain natriuretic polypeptide level as a marker of risk for thromboembolism in patients with nonvalvular atrial fibrillation.Stroke,2002,33:1005-1010.
  • 8Horie H,Tsutamoto T,Minai K,et al.Brain natriuretic peptide predicts chronic atrial fibrillation after ventricular pacing in patients with sick sinus syndrome.Jpn Circ J,2000,64:965-970.
  • 9Wazni OM,Martin DO,Marrouche NF,et al.Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery.Circulation,2004,110:124-127.
  • 10Rossi A,Enriquez-Sarano M,Burnett JC,et al.Natriuretic peptide levels in atrial fibrillation:a prospective hormonal and Doppler-echocardiographic study.J Am Coll Cardiol,2000,35:1256-1262.

二级参考文献30

  • 1Maekawa K,Sudoh T,Furusawa M,et al.Cloning and sequence analysis of cDNA encoding a precursor for porcine brain natriuretic peptide.Biochem Biophys Res Commun,1988,157:410-416.
  • 2Ogawa E,Saito Y,Kuwahara K,et al.Fibronectin signaling stimulates BNP gene transcription by inhibiting neuron-restrictive silencer element-dependent repression.Cardiovasc Res,2002,53:451-459.
  • 3Lee YJ,Lin SR,Shin SJ,et al.Brain natriuretic peptide is synthesized in the human adrenal medulla and its messenger ribonucleic acid expression along with that of atrial natriuretic peptide are enhanced in patients with primary aldosteronism.J Clin Endocr
  • 4Kohno M,Horio T,Yokokawa K,et al.Brain natriuretic peptide as a cardiac hormone in essential hypertension.Am J Med,1992,92:29-34.
  • 5Tateyama H,Hino J,Minamino N,et al.Concentrations and molecular forms of human brain natriuretic peptide in plasma.Biochem Biophys Res Commun,1992,185:760-767.
  • 6Kone BC.Molecular biology of natriuretic peptides and nitric oxide synthases.Cardiovasc Res,2001,51:429-441.
  • 7Tremblay J,Desjardins R,Hum D,et al.Biochemistry and physiology of the natriuretic peptide receptor guanylyl cyclases.Mol Cell Biochem,2002,230:31-47.
  • 8Stockand JD,Sansom SC.Regulation of filtration rate by glomerular mesangial cells in health and diabetic renal disease.Am J Kidney Dis,1997,29:971-981.
  • 9La Villa G,Bisi G,Lazzeri C,et al.Cardiovascular effects of brain natriuretic peptide in essential hypertension.Hypertension,1995,25:1053-1057.
  • 10Silberbach M,Roberts CT Jr.Natriuretic peptide signalling:molecular and cellular pathways to growth regulation.Cell Signal,2001,13:221-231.

共引文献74

同被引文献30

  • 1胡大一,张鹤萍,孙艺红,姜立清.华法林与阿司匹林预防非瓣膜性心房颤动患者血栓栓塞的随机对照研究[J].中华心血管病杂志,2006,34(4):295-298. 被引量:162
  • 2周京敏,周俊,潘文志,郝颖,金雪娟,刘少稳,蔡乃绳,葛均波.左室收缩功能正常的心房颤动患者血清NT-pro-BNP水平的变化及影响因素探讨[J].中国临床医学,2007,14(2):129-131. 被引量:13
  • 3Aviles RJ , Martin DO , Apperson Hansen C, et al. Inflammation as a risk factor for atrial fibrillatlon[J]. Circulation, 2003, 108 (24):3 006.
  • 4Chung MK, Martin DO, Sprecher D, et al . C - reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation[J]. Circulation, 2001, 104(24):2 886-2 891.
  • 5Anderson JL, Allen - Maycock CA, Lappe DL, et al. Frequency of elevation of C- reactive protein in atrial fibrillation[J ]. Am J Cardiol, 2004, 94 (10):1 255.
  • 6Kamath S, Blann AD, Chin BS, et al . A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy [J]. Ettr Heart J, 2002, 23 : 1 788 - 1 795.
  • 7Li - Saw - Hee FL, Blann AD , Lip GY, et al . Effects of fixed low- does warfrin, aspirin - warfarin combination therapy , and does- adjust warfrin on thromhogenesis in chronic atrial fibrillation[J]. Stroke, 2000, 31 : 828 - 833.
  • 8Koefoed BG, Feddersen C , Gullqv AL , et al . Effects of fixed minidose warfrin , conventional does warfrin and aspirin on INR and prothrombin fragment in patients with atrial fibrillation[J]. Thromb Haemost, 1997, 77:845 - 848.
  • 9Rossi A , Enriquez - Sarano M, Burner JC, et al. Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler- echo - cardiographic study [ J ]. J Am Coll Cardiol, 2000, 35:1 256-1 262.
  • 10Silvet H, Young - Xu Y, WaUeigh D, et al. Brain natriuretic peptide is d evated in outpatients with atrial fibrillation[J]. Am J Cardiol, 2003, 92:1 124-1 127.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部